Varex Imaging (NASDAQ:VREX) Updates Q3 2026 Earnings Guidance

Varex Imaging (NASDAQ:VREX) issued an update on its third quarter 2026 earnings guidance on Thursday morning. The company provided EPS guidance of 0.150-0.300 for the period, compared to the consensus EPS estimate of 0.220. The company issued revenue guidance of $210.0 million-$225.0 million, compared to the consensus revenue estimate of $215.5 million.

Varex Imaging Trading Down 3.0%

NASDAQ VREX traded down $0.36 on Thursday, reaching $11.81. The company had a trading volume of 563,251 shares, compared to its average volume of 315,834. Varex Imaging has a 52 week low of $6.76 and a 52 week high of $14.56. The stock’s 50 day moving average is $11.58 and its 200-day moving average is $12.17. The company has a quick ratio of 1.87, a current ratio of 3.89 and a debt-to-equity ratio of 0.75. The stock has a market cap of $494.84 million, a price-to-earnings ratio of -7.20 and a beta of 0.96.

Varex Imaging (NASDAQ:VREX) last posted its earnings results on Thursday, May 7th. The company reported $0.21 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.22 by ($0.01). The company had revenue of $216.00 million for the quarter, compared to analyst estimates of $216.92 million. Varex Imaging had a positive return on equity of 8.43% and a negative net margin of 7.92%.Varex Imaging has set its Q3 2026 guidance at 0.150-0.300 EPS. Equities analysts predict that Varex Imaging will post 0.93 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on the company. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Varex Imaging in a research report on Friday, March 27th. Jefferies Financial Group reissued a “hold” rating and set a $14.50 target price on shares of Varex Imaging in a research note on Monday, February 2nd. Zacks Research raised shares of Varex Imaging from a “hold” rating to a “strong-buy” rating in a research note on Monday, April 13th. B. Riley Financial reiterated a “buy” rating on shares of Varex Imaging in a report on Thursday, February 12th. Finally, Wall Street Zen lowered shares of Varex Imaging from a “strong-buy” rating to a “buy” rating in a report on Saturday, April 25th. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Varex Imaging presently has an average rating of “Moderate Buy” and a consensus target price of $16.17.

Insider Transactions at Varex Imaging

In other Varex Imaging news, Director Jay K. Kunkel sold 4,510 shares of the business’s stock in a transaction dated Friday, March 20th. The shares were sold at an average price of $11.14, for a total transaction of $50,241.40. Following the sale, the director directly owned 23,450 shares of the company’s stock, valued at $261,233. The trade was a 16.13% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Insiders own 4.60% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the stock. Quarry LP acquired a new position in shares of Varex Imaging during the 3rd quarter worth approximately $64,000. BNP Paribas Financial Markets increased its holdings in Varex Imaging by 18.5% during the second quarter. BNP Paribas Financial Markets now owns 13,045 shares of the company’s stock worth $113,000 after buying an additional 2,036 shares during the last quarter. Aquatic Capital Management LLC bought a new stake in Varex Imaging during the third quarter worth $117,000. Cerity Partners LLC acquired a new stake in Varex Imaging in the second quarter valued at $123,000. Finally, The Manufacturers Life Insurance Company grew its position in shares of Varex Imaging by 10.4% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 15,302 shares of the company’s stock valued at $133,000 after acquiring an additional 1,442 shares during the period.

About Varex Imaging

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.